© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Nicarbazin didn’t appear in the agricultural world overnight. Its journey started back in the mid-20th century, with researchers on both sides of the Atlantic searching for new answers to the growing problem of coccidiosis in poultry. Some of the earliest studies from the 1950s showed nicarbazin could knock down coccidia in birds, dramatically reducing mortality. The push to develop effective feed-based anticoccidials became urgent as the poultry industry ramped up. Nicarbazin was one of the first successful synthetic compounds to earn its place on farms, quickly outpacing earlier chemical attempts by proving both reliable and cost-effective. Over the years, its role kept shifting: some areas started phasing it out because of regulatory shifts, but in regions battling tough coccidia strains, nicarbazin held steady as a solution grounded in decades of use and research.
Nicarbazin stands as a white, odorless powder that targets coccidia—single-celled parasites that thrive inside the gut of chickens and turkeys. Poultry producers mix it directly into feed for growing broilers. Early on, feed mills adopted nicarbazin because it didn’t break down quickly in storage and made its way through mixing equipment neatly. The product contains two main ingredients: 4,6-dimethylpyrimidin-2-ylcarbamoyl (N,N′-bis(4-nitrophenyl)urea), giving it robust anticoccidial activity. Over seventy years after launch, it’s still showing up in commercial starter and grower feeds, often as part of rotation or shuttle programs to slow resistance.
As a technical powder, nicarbazin’s water solubility stays low, which means it rides along the digesta in the bird’s gut rather than slipping directly into solutions. The melting point sits around 253-255°C, making it stable for the tough temperatures in feed processing. What stands out is the compound’s density and fine granularity—feed manufacturers count on it staying consistent from sack to pellet. Chemically, C19H18N6O6 remains dense in nitro and urea sub-groups, which play different roles in how it interacts with biological material. Nicarbazin doesn’t degrade quickly under normal warehouse conditions and can last through the typical shelf life of poultry feeds.
Feed-grade nicarbazin products usually carry at least 97% active ingredient by weight, while impurities like water or related compounds must stay minimal. Labeling calls for the clear display of purity, production batch, and expiration. In regulated markets, feed labels must spell out usage limits (up to 125 ppm for broilers in many areas), withdrawal times (often 5-7 days), and species specificity. Companies producing nicarbazin must adhere to detailed technical protocols—stability testing, impurity profiling, and compliance with local residue standards top the checklist. Labels also warn against use in laying hens, since residues can linger in eggs.
Synthetic routes for nicarbazin have grown more sophisticated since its mass production began. Early chemists prepared it by reacting 4,6-dimethyl-2-hydroxypyrimidine with 4-nitrophenyl isocyanate under controlled heat, giving rise to a carbamoyl linkage crucial for its activity. These days the process often runs in jacketed reactors under tightly regulated conditions to hold temperature and pH steady. Purification happens through repeated recrystallization and filtration, separating active product from precursors and leftover solvents. Improvements in ‘green’ chemistry—like solvent recovery, water reuse, and tighter emission controls—continue to shrink the environmental footprint of each batch produced.
Core to nicarbazin’s function is its ability to bind with cell membranes inside the parasite. The nitrophenyl groups play a direct role: they disrupt ion balance and halt the development of Eimeria oocysts. Over the years, researchers tried to tweak nicarbazin’s side chains to improve absorption or activity. Most modifications haven’t outperformed the original molecule’s balance of toxicity and benefit. Attempts to create more water-soluble versions have stumbled; efficacy often drops, or the new compounds clear from the bird’s body too quickly. Recent work with combination products—pairing nicarbazin with other anticoccidials like narasin or salinomycin—shows promise, extending control over more Eimeria species and slowing resistance, especially in tough production cycles.
Nicarbazin’s chemical mouthful (4,4′-dinitrocarbanilide-2-hydroxy-4,6-dimethylpyrimidine complex) is rarely found outside scientific literature. In the field, it’s known under names like Coxystat, Nicarb, and DNC, depending on manufacturer and market. Feed labels often abbreviate or list the trade name, with international codes required for export or regulatory paperwork. Other names—such as DNCB-P or AT-110—pop up in scientific trials or patent filings.
Safety rules around nicarbazin come with hard-won experience. Feed mills enforce dust control, with workers donning masks and gloves. Ingestion or inhalation at high levels can irritate mucous membranes or trigger headaches. Storage away from oxidizers, in sealed, labeled containers, keeps accidents down. Regulations ban its use in laying hens and set strict residue limits in meat; every load must meet government monitoring for drug carryover. State-of-the-art labs run ELISA or HPLC tests to detect residues at low parts-per-million. International standards through Codex Alimentarius and national EFSA guidelines all focus on maintaining a wide safety margin for human consumers and animal health.
Broiler production still defines nicarbazin’s main territory. Chickens from hatch to five weeks get the protection, especially inside high-density barns where coccidiosis can rip through flocks. Some turkey operations use it, though turkeys show sensitivity so doses run lower and coverage is selective. Most modern programs pair nicarbazin with ionophores, rotating products through cycles to dodge resistance. It rarely enters the diets of breeders or egg layers. Use has declined in regions where vaccination and more targeted management hold sway, but in many fast-growing markets where biosecurity isn’t perfect, coccidial pressure stays high—and nicarbazin remains a front-line defense.
Companies and university labs never really stepped back from researching nicarbazin, even after its initial surge. Key focus points: tracking how Eimeria species adapt to its presence and tweaking administration schedules for maximum effect. Recent research digs into synergy, blending nicarbazin with phytochemicals, probiotics, or new delivery systems like microencapsulation. Some teams investigate molecular targets, hoping to deepen understanding of how resistance develops and whether newer analogues might balance safety with broader activity. Several trials compare nicarbazin-based approaches to live vaccines, judging not just clinical results but also impacts on gut flora and growth performance.
Toxicity always trails behind strong drug candidates. Trials going back decades detail nicarbazin’s effects at doses well above those found in feed. Lab animals show signs of liver and kidney changes only at massive exposures. In chickens, overdosing brings sluggish growth and anemia, while proper use nearly always matches strong health and steady gain. One persistent concern: consuming eggs from hens exposed to nicarbazin can carry residues, prompting bans for laying flocks. Long-term studies in rodents and target animals show low carcinogenicity, with regulators consistently rating it as low-risk for both farm workers and consumers when label precautions hold. Environmental fate studies show minimal persistence in soil, and breakdown through microbial action keeps long-term buildup in check.
The fight against coccidiosis keeps shifting with livestock movements and regulatory updates. Some see nicarbazin becoming more niche, mainly used in rotation where resistance to other drugs rages. Where pressure for residue-free meat tightens, vaccines and “natural” anticoccidials are gaining ground. Feed additive makers look for ways to stretch efficacy, including new blends and delivery systems that dodge both coccidia and regulatory scrutiny. Nicarbazin won’t vanish in the coming decade; the lesson from past decades is that no single tool—whether chemical or biological—handles the full complexity of coccidiosis on its own. Flexible programs, deep monitoring, and ongoing research into both mechanisms and safe use will remain central to how this compound supports global food supply.
Nicarbazin shows up in my feed-store memory as bags with warnings and official logos, always headed for commercial chicken houses. It’s a compound that goes right into the daily feed of broilers—those chickens people eat every week—playing a key part in disease control. Farmers rely on it because it keeps a parasite called coccidia from wiping out flocks, which helps keep the price of chicken reasonable and shelves stocked. Coccidiosis can kill young birds fast, leading to big losses and panic runs to the vet. By using nicarbazin, chicken producers head off this destruction and keep birds healthier throughout their short lives.
Once coccidiosis gets into a barn, it doesn’t respect hard work or clean boots. I’ve watched how the disease can burn through a flock, causing birds to become lethargic, stop growing, and sometimes die outright. The real cost isn’t just the lost animals—it’s all the feed put in and time spent, wasted in a matter of days. Nicarbazin attacks the parasite at a critical stage, cutting the risk of an outbreak. Research published in journals like Poultry Science backs this up, showing that the right amount in feed can reduce infection rates significantly, saving entire barns from disaster. The FDA approves its use with strict guidelines for dosage and withdrawal times to ensure people aren’t exposed to unsafe leftovers in food products.
Across the country, chicken is affordable protein, making up a big slice of family meals. Any disease that messes with the production chain can spike prices and hurt families who don’t have room in the grocery budget. By keeping flocks healthy, nicarbazin supports reliable supply and steady prices—a big deal when inflation bites. Producers can only use it up to a certain age of the chicken; broilers get taken off the compound before slaughter, giving time for any residue to leave their system. That’s not just a business choice. Regulators check to keep food safe, and random tests back up this process on the ground. Data from the USDA and similar bodies confirm that chicken meat on store shelves is consistently below set residue limits when handled as required.
Medications like nicarbazin bring up tough questions about animal health and long-term farming practices. Some birds and regions have developed resistance to coccidiostats, and overuse builds up this problem over years. Across the industry, there’s growing interest in rotation of treatments—switching between different compounds regularly—and looking at alternatives such as vaccines or better barn management. I’ve talked with producers who mix in more natural approaches, like raising bedding quality, keeping water clean, and limiting flock density. The shift won’t happen overnight. Commercial broiler operations have a narrow window for changing practices, with tight deadlines between hatching and market weight.
Parents buying chicken want food safety and animal welfare right up there with price. That’s why scientists, farmers, and regulators keep a close eye on how tools like nicarbazin fit into broader meat production. With ongoing reviews, updated guidelines, and transparent reporting, everyone up and down the food chain gets a say. For now, this compound provides a lifeline for many farms, but the push for sustainable, lower-residue or residue-free options will likely only get stronger as technology and consumer values shift.
Nicarbazin popped up in the 1950s as a tool against coccidiosis. This disease can easily run wild in chicken flocks, causing lost growth and death. Nearly every commercial poultry producer has struggled with coccidiosis at some point, especially in places with crowded or damp flock conditions. Growing up on a small farm, there were weeks when we saw scrawny, sick birds, and vets would mention parasites as the common culprit. Nicarbazin’s story started as a life-saver for many operations that just couldn’t afford to lose birds to preventable illness.
Since the beginning, food safety agencies from Europe, the U.S., Brazil, and China have paid close attention to drugs like nicarbazin. The guidelines usually stick to strict residue limits in meat and eggs. For example, the European Food Safety Authority and the FDA both approved nicarbazin with a safe residue limit, as long as farmers heed the recommended withdrawal period before slaughter—usually between 5 and 9 days. These extra days let the drug clear from a chicken’s system. Stories get passed around by poultry workers about surprise spot checks from authorities; nobody wants to get caught skipping that waiting window.
Most research points out that, when used as directed, nicarbazin leaves very little residue behind. A review by the World Health Organization noted that after proper use and time for clearance, “no significant residues remain,” so meat and eggs stay below strict safety limits. On a technical level, tests show that residues usually measure far lower than the already conservative limits set by regulators. Sometimes, someone forgets about accidental overdosing or birds eating contaminated feed longer than needed, but official reports on major food safety failures tied to nicarbazin just don’t turn up.
Critics of farm drugs bring up good points: we never fully escape the risk of resistance. Some also worry about mixing different medicines or feed errors. Once, a friend’s small hatchery mixed up medicated and grower feeds, and their vet gave advice about keeping withdrawal logs just in case. Watching these practices up close, keeping clean records and labeling goes further than any warning label. Veterinary toxicologists tracked birds getting nicarbazin for months and didn’t find developmental issues, reproductive changes, or major organ troubles at the legal doses.
Plenty of chicken raisers ask about antibiotic-free methods. Some try essential oils or fancy probiotics, with mixed results. I walked a few trial barns, and while herbs can help gut health, they won’t totally stop outbreaks during humid weeks. Vaccines for coccidiosis now get used more and can cut the need for drugs, but cost and consistency still stump many smaller farms. It always comes back to solid husbandry—regular cleaning, proper bedding, and rotating pastures.
Safe poultry products don’t just rely on the drug itself, but on the system behind it. Using nicarbazin means following the dose chart, withdrawal times, and record-keeping. Every credible producer should invite regular testing and be open about what’s used. Consumers deserve that trust. In farming, shortcuts only lead to headaches and losses later. Nicarbazin has earned its spot by keeping its promises when managed with care, but no step matters more than a farm’s day-to-day discipline.
Nicarbazin has shown reliable control against coccidiosis in broiler farms for over half a century. Coccidiosis attacks fast, often before a farmworker spots the problem. I remember inspecting flocks that just started looking droopy, but under the surface, oocyst counts already tell a story. A drug like Nicarbazin helps keep outbreaks in check. Knowing how much to use can make the difference between a productive house and lost profits.
For broilers, manufacturers and veterinary handbooks frequently specify inclusion rates of either 100 or 125 parts per million (ppm) of Nicarbazin in feed. That boils down to 100–125 mg per kilogram of complete feed. Feed mills mix concentrate straight into the mash or pellet, and accuracy at this step truly matters—even a slip-up of a few milligrams can mean underdosing or ranchers dealing with unnecessary drug residues in meat.
In my own experience walking feed mills, precision is both an everyday detail and a legal requirement. In the United States, the FDA’s Green Book sets approved feed levels. In the European Union, the maximum stays lower, often around 70 mg/kg feed. Outside these regions, guidelines tend to mirror international recommendations or national agriculture boards. It’s common for veterinarians to verify calculations during quality control rounds. Mistakes prompt both official scrutiny and economic loss: birds facing overdose risk kidney stress, especially in hot climates where water intake goes up.
An optimal Nicarbazin dosage avoids two problems: disease breakthrough and drug residue. Under-dosing makes it easier for resistant coccidia to spread. On the flip side, excess Nicarbazin leads to residue in meat and eggs, which food regulators test for with sensitive equipment. Farm recalls and lost customer trust follow reports of residue that top allowable limits. I've seen growers struggle to regain market access after such lapses. Once that relationship with the buyer cracks, it rarely snaps back.
Changes in feed intake add complexity. Birds eat less during cool periods and more when it’s hot. Growers sometimes ask if they should adjust the concentration in feed. Official guidance says keep the dose based on feed, not body weight, because metabolic rates differ so much. My veterinarian colleagues watch for subtle signs of overdose like pale combs, runny manure, or dips in growth rate.
Routine checks using batch validation and feed assays help spot problems early. On farms, regular recordkeeping of which drug goes into which batch, and for how many days, gives clarity if an inspector drops by. Withdrawal periods also protect consumers: most programs require that Nicarbazin feeding stops at least 4–5 days before slaughter to clear residues. This window preserves both food safety and export potential.
Backing up the dosing process, many poultry companies use hazard analysis and critical control points (HACCP) in their feed mills. Automated micro-dosing equipment can bring peace of mind by reducing human error. Some integrators build routine staff training days right into their schedules. Lab personnel test finished feed for drug concentration, and that extra step has paid off for some companies dodging regulatory trouble.
Keeping Nicarbazin use on target isn’t only about compliance; it also protects animal health, farmer income, and consumer trust. Open communication between veterinarians, feed mill operators, and farm staff works best to keep every batch safe and effective.
Nicarbazin has made a name in the world of poultry farming, especially for farms striving to keep coccidiosis in check. Coccidiosis is a gut disease caused by a parasite known as Eimeria. Once it enters a flock, it quickly messes with digestive health, slows growth, and can devastate a farm’s bottom line. Over the years, producers have leaned on nicarbazin because it packs power against the parasite, giving birds a fighting chance during the most vulnerable growth stages.
The secret behind nicarbazin’s punch lies in its dual-component formula. It disrupts the life cycle of Eimeria inside the chicken’s gut, stopping the parasite before it matures and multiplies. By keeping parasite numbers low, the medicine helps birds keep eating, growing, and converting feed without the drag of intestinal illness. With healthier birds, farmers see fewer losses and better overall flock performance, especially in large commercial operations where an outbreak can ripple into big financial setbacks.
I have watched small family farms wrestle with coccidiosis and juggle choices about medicine. Relying too heavily on a single tool like nicarbazin stirs up trouble down the road, since parasites can become resistant. This is not a conspiracy cooked up by pharma companies—years of data and boots-on-the-ground experience prove it. Flocks in regions that never rotate their anticoccidials begin to show weaker responses, meaning birds get sick more easily despite medication, and the safety net frays. Using nicarbazin alongside other controls—sanitation, vaccination, and well-timed rotation—keeps resistance from building up too fast and extends the working life of this trusted compound.
The modern shopper keeps a sharp eye on what goes into their food. Nicarbazin leaves behind residues in poultry tissue, which has led agencies like the FDA and European regulators to set clear withdrawal times. Meat from birds treated with nicarbazin has to follow strict withdrawal schedules so no unwanted traces end up on the dinner table. That means all producers using this product need solid record-keeping and staff training to meet these demands. I have talked with poultry vets who work overtime during inspections to double-check that handlers and farm managers follow each step. This process builds trust from farm to fork.
Technology and practical wisdom both play a role in future coccidiosis control. New approaches, including better vaccines and probiotics, share the spotlight with time-tested drugs like nicarbazin. Farmers who talk to their veterinarians about rotation plans stay ahead of problems most of the time. More research has helped identify low-resistance management strategies, and sharing results openly with producers closes the gap between science and daily life on the farm. With unpredictable weather and rising feed costs, solutions that blend proven medicine, hands-on farm management, and consumer focus will keep flock health where it belongs—and food supply steady for everyone.
People who raise chickens for eggs or meat know that every product that goes into livestock gets closely monitored, especially medications. Nicarbazin is a well-known anticoccidial ― a drug protecting chickens from one of the nastiest poultry diseases, coccidiosis. It keeps birds healthy, but it’s not something anyone would want in their dinner. Regulatory agencies insist on a withdrawal period for a reason. This is the time between the last dose and when the animal product is safe to eat. In practical terms, farmers follow these rules to keep residues out of the food supply and to avoid regulatory trouble.
The usual withdrawal period for nicarbazin in broiler chickens ranges from 4 to 7 days. During this time, birds get no more of the medication, allowing their bodies to clear any chemical residues. Studies by food safety authorities show that residues drop below safe thresholds if the withdrawal rules are followed, so consumers can eat chicken meat without worrying about leftover drugs. Countries vary a bit in their rules, but most stick to a very similar timeline. If birds get harvested too soon after taking nicarbazin, residue could end up in meat that goes to market.
Nobody gives medicine to their flock expecting trouble, but every compound comes with its own risks. In my opinion, nicarbazin earned trust for safety when used as directed, yet issues pop up when farmers ignore dose, duration, or combine products the wrong way. Chickens sometimes react with loose droppings or decreased weight gain if they get too much of this drug, especially younger birds. Under hot weather conditions, birds on nicarbazin have faced heat stress more often. Veterinary sources document this heat risk, tying it to the drug’s effects on body temperature regulation.
Egg-laying hens need special mention. Farmers who switch birds from meat to eggs sometimes overlook the carryover of anticoccidials. Even a small amount of nicarbazin during laying can lead to discolored or mottled eggs ― a headache for anyone selling table eggs because consumers notice. The change to eggshell color doesn’t hurt the chicken, but it hits wallet and reputation. Overuse increases chances of kidney and liver strain, too, though that’s rare on regulated poultry farms that avoid overdosing.
A withdrawal period works only if farmers stick to what’s printed on the product label. Veterinarians play a key role here; they don’t just sell treatments, they set the rules for using them. Documentation and record-keeping are essential routines on responsible farms. I’ve seen producers keep daily medication logs, check withdrawal timelines on flock calendars, and run residue checks to prove birds are clean at slaughter.
One positive shift comes as more farmers and feed suppliers rotate different anticoccidials or use vaccine programs to cut down chemical treatments. This can lower drug resistance and let flocks rest between cycles. Where nicarbazin fits in, it should always follow correct timing, proper dose, and the official withdrawal period. Any leftover product goes back into a locked cabinet, not recycled into the next batch.
Consumers rely on farmers to protect them from drug residues, and for the most part, monitoring works. The industry gets the message: keep food safe and customer trust stays intact. Skipping the withdrawal rule invites legal and market trouble no farm wants.
| Names | |
| Preferred IUPAC name | 4,4'-[(2-Hydroxy-4,6-dimethylpyrimidine-1,3-diyl)diimino]dibenzenecarboxamide |
| Other names |
Coxarox Coxistac Nibasin NIC NCZ |
| Pronunciation | /naɪˈkɑːrbəzɪn/ |
| Identifiers | |
| CAS Number | 330-95-0 |
| Beilstein Reference | 132157 |
| ChEBI | CHEBI:7663 |
| ChEMBL | CHEMBL2106340 |
| ChemSpider | 2157 |
| DrugBank | DB11476 |
| ECHA InfoCard | 100.066.013 |
| EC Number | EC 3.2.1.131 |
| Gmelin Reference | 87138 |
| KEGG | C14215 |
| MeSH | D017929 |
| PubChem CID | 32361 |
| RTECS number | SZ9950000 |
| UNII | 759283J1LU |
| UN number | 3077 |
| CompTox Dashboard (EPA) | DJ1LF40M2G |
| Properties | |
| Chemical formula | C19H18N6O6 |
| Molar mass | 578.546 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | Density: 1.59 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 0.24 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 13.91 |
| Basicity (pKb) | 11.83 |
| Dipole moment | 3.64 D |
| Thermochemistry | |
| Std enthalpy of formation (ΔfH⦵298) | Nicarbazin: "Std enthalpy of formation (ΔfH⦵298) = -776.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -4934 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | QG60C002 |
| Hazards | |
| Main hazards | May cause damage to organs through prolonged or repeated exposure. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS07, GHS09 |
| Signal word | Warning |
| Hazard statements | H351: Suspected of causing cancer. |
| Precautionary statements | P264, P270, P273, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 2-1-0 |
| Autoignition temperature | > 371°C |
| Lethal dose or concentration | LD50 (oral, rat): 10,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): 10,000 mg/kg (oral, rat) |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Nicarbazin: Not established |
| REL (Recommended) | 125-250 mg/kg |
| Related compounds | |
| Related compounds |
Dinitolmide Robenidine Clopidol |
